Signal pathways of melanoma and targeted therapy
W Guo, H Wang, C Li - Signal transduction and targeted therapy, 2021 - nature.com
Melanoma is the most lethal skin cancer that originates from the malignant transformation of
melanocytes. Although melanoma has long been regarded as a cancerous malignancy with …
melanocytes. Although melanoma has long been regarded as a cancerous malignancy with …
Nanoparticle drug delivery systems and their applications as targeted therapies for triple negative breast cancer
The therapeutic effect of highly malignant triple negative breast cancer (TNBC) is negatively
affected by the formation of tumor cell resistant clone and the severe toxicity of …
affected by the formation of tumor cell resistant clone and the severe toxicity of …
Detection of immunogenic cell death and its relevance for cancer therapy
Chemotherapy, radiation therapy, as well as targeted anticancer agents can induce clinically
relevant tumor-targeting immune responses, which critically rely on the antigenicity of …
relevant tumor-targeting immune responses, which critically rely on the antigenicity of …
The role of tumor microenvironment in cancer metastasis: Molecular mechanisms and therapeutic opportunities
Simple Summary Metastasis, the process by which cancer cells escape primary tumor site
and colonize distant organs, is responsible for most cancer-related deaths. The tumor …
and colonize distant organs, is responsible for most cancer-related deaths. The tumor …
Biology and therapeutic potential of interleukin-10
M Saraiva, P Vieira, A O'garra - Journal of Experimental Medicine, 2019 - rupress.org
The cytokine IL-10 is a key anti-inflammatory mediator ensuring protection of a host from
over-exuberant responses to pathogens and microbiota, while playing important roles in …
over-exuberant responses to pathogens and microbiota, while playing important roles in …
[HTML][HTML] Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
Background Treatment with immune checkpoint blockade (ICB) with agents such as anti-
programmed cell death protein 1 (PD-1), anti-programmed death-ligand 1 (PD-L1), and/or …
programmed cell death protein 1 (PD-1), anti-programmed death-ligand 1 (PD-L1), and/or …
Recent updates of transarterial chemoembolilzation in hepatocellular carcinoma
Y Chang, SW Jeong, J Young Jang… - International journal of …, 2020 - mdpi.com
Transarterial chemoembolization (TACE) is a standard treatment for intermediate-stage
hepatocellular carcinoma (HCC). In this review, we summarize recent updates on the use of …
hepatocellular carcinoma (HCC). In this review, we summarize recent updates on the use of …
Cancer and the immune system: the history and background of immunotherapy
M Abbott, Y Ustoyev - Seminars in oncology nursing, 2019 - Elsevier
Objective This article will outline the link between the immune system and cancer, and
provide a historical timeline of immunotherapy developmental milestones. Data Sources …
provide a historical timeline of immunotherapy developmental milestones. Data Sources …
TGF-β1–a truly transforming growth factor in fibrosis and immunity
Abstract 'Jack of all trades, master of everything'is a fair label for transforming growth factor
β1 (TGF-β)–a cytokine that controls our life at many levels. In the adult organism, TGF-β1 is …
β1 (TGF-β)–a cytokine that controls our life at many levels. In the adult organism, TGF-β1 is …
Single-cell map of diverse immune phenotypes in the breast tumor microenvironment
E Azizi, AJ Carr, G Plitas, AE Cornish, C Konopacki… - Cell, 2018 - cell.com
Knowledge of immune cell phenotypes in the tumor microenvironment is essential for
understanding mechanisms of cancer progression and immunotherapy response. We …
understanding mechanisms of cancer progression and immunotherapy response. We …